Phase II study of combined chemotherapy with irinotecan and S-1 (IRIS) plus bevacizumab in patients with inoperable recurrent or advanced colorectal cancer

By Komatsu Yoshito   Yuki Satoshi   Sogabe Susumu   Fukushima Hiraku   Nakatsumi Hiroshi   Kobayashi Yoshimitsu   Iwanaga Ichiro   Nakamura Michio   Hatanaka Kazuteru   Miyagishima Takuto   Kudo Mineo   Munakata Masaki   Meguro Takashi   Tateyama Miki   Sakata Yuh  

Acta Oncologica, Vol. 51, Iss. 7, 2012-09 ,pp. : 867-872

Informa Healthcare

Access to resources Recommend Favorite

Feasibility study of adjuvant chemotherapy with S-1 (TS-1; tegafur, gimeracil, oteracil potassium) for gastric cancer

By Kinoshita Taira   Nashimoto Atsushi   Yamamura Yoshitaka   Okamura Takeshi   Sasako Mitsuru   Sakamoto Junichi   Kojima Hiroshi   Hiratsuka Masahiro   Arai Kuniyoshi   Sairenji Motonori   Fukushima Norimasa   Kimura Hironobu   Nakajima Toshifusa  

Gastric Cancer, Vol. 7, Iss. 2, 2004-06 ,pp. : 104-109

Springer Publishing Company

Access to resources Recommend Favorite

Phase I clinical and pharmacokinetic/pharmacogenetic study of a triplet regimen of S-1/irinotecan/oxaliplatin in patients with metastatic colorectal or gastric cancer

By Park Sook   Hong Yong   Lim Hyeong-Seok   Seong Moon-Woo   Kong Sun-Young   Kim Sun   Park Young-Iee   Jung Kyung  

Cancer Chemotherapy and Pharmacology, Vol. 72, Iss. 5, 2013-11 ,pp. : 953-964

Springer Publishing Company

Access to resources Recommend Favorite

Second-line chemotherapy with irinotecan plus cisplatin after the failure of S-1 monotherapy for advanced gastric cancer

By Takahari Daisuke   Shimada Yasuhiro   Takeshita Shigeyuki   Nishitani Hitoshi   Takashima Atsuo   Okita Natsuko   Hirashima Yoshinori   Kato Ken   Hamaguchi Tetsuya   Yamada Yasuhide   Shirao Kuniaki  

Gastric Cancer, Vol. 13, Iss. 3, 2010-08 ,pp. : 186-190

Springer Publishing Company

Access to resources Recommend Favorite

Feasibility study of S-1 adjuvant chemotherapy in patients with colorectal cancer

By Ogawa Masaichi   Watanabe Michiaki   Kobayashi Tetsuya   Eto Ken   Oda Akihiro   Anan Tadashi   Hayashi Takenori   Mitsuyama Yoshinobu   Yanaga Katsuhiko  

International Journal of Clinical Oncology, Vol. 18, Iss. 4, 2013-08 ,pp. : 678-683

Springer Publishing Company

Access to resources Recommend Favorite